Outcomes in patients discharged with extended venous thromboembolism prophylaxis after hospitalization with COVID-19.

Love PatelAshley StenzelChristopher Van HoveAbbey SidebottomRajesh KethireddyNgoc HaDavid BeddowJesse ManungaGhaziuddin QadriJustin KirvenNedaa Skeik

Published in: Vascular medicine (London, England) (2023)

Patients discharged on extended VTE prophylaxis after hospitalization due to COVID-19 had similar thrombotic events on follow-up. However, use of extended VTE prophylaxis was associated with improved 30- and 90-day survival and reduced risk of 30-day inpatient readmission.

Keyphrases

venous thromboembolism
sars cov
direct oral anticoagulants
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
skeletal muscle
insulin resistance
free survival
weight loss
acute care